Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Gains from Investment Securities (2021 - 2025)

Biote (BTMD) has 4 years of Gains from Investment Securities data on record, last reported at $4.2 million in Q4 2024.

  • For Q4 2024, Gains from Investment Securities changed N/A year-over-year to $4.2 million; the TTM value through Dec 2024 reached $4.2 million, down 68.68%, while the annual FY2024 figure was $4.2 million, 48.4% down from the prior year.
  • Gains from Investment Securities reached $4.2 million in Q4 2024 per BTMD's latest filing, down from $11.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $14.4 million in Q4 2021 and bottomed at -$13.8 million in Q2 2021.
  • Average Gains from Investment Securities over 4 years is $925144.6, with a median of -$575000.0 recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: crashed 2768.98% in 2022, then skyrocketed 446.95% in 2023.
  • A 4-year view of Gains from Investment Securities shows it stood at $14.4 million in 2021, then crashed by 104.0% to -$575000.0 in 2022, then skyrocketed by 2150.96% to $11.8 million in 2023, then plummeted by 64.38% to $4.2 million in 2024.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $4.2 million in Q4 2024, $11.8 million in Q2 2023, and $1.6 million in Q1 2023.